Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials

National Center for Immunization and Respiratory Diseases, 2009, Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the (ACIP), 2009, MMWR Recomm Rep, 58, 1 WHO Centers for Disease Control and Prevention, 2009, Update: influenza activity—United States, April–August 2009, MMWR Morb Mortal Wkly Rep, 58, 1009 World Health Organization, 2009, New influenza A (H1N1) virus: global epidemiological situation, June 2009, Wkly Epidemiol Rec, 84, 249 Kelly, 2009, Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection, Med J Aust, 191, 146, 10.5694/j.1326-5377.2009.tb02723.x Centers for Disease Control and Prevention (CDC), 2009, Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection–United States, April–August 2009, MMWR Morb Mortal Wkly Rep, 58, 941 Vaillant, 2009, Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009, Euro Surveill, 14, 19309, 10.2807/ese.14.33.19309-en Itoh, 2009, In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses, Nature, 460, 1021, 10.1038/nature08260 Munster, 2009, Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets, Science, 325, 481, 10.1126/science.1177127 Maines, 2009, Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice, Science, 325, 484, 10.1126/science.1177238 Brouwers, 2009, Economic consequences to society of pandemic H1N1 influenza 2009–preliminary results for Sweden, Euro Surveill, 14, 19333, 10.2807/ese.14.37.19333-en Yang, 2009, The transmissibility and control of pandemic influenza A (H1N1) virus, Science, 326, 729, 10.1126/science.1177373 Food and Drug Administration Center for Biologics Evaluation and Research Office of Vaccines Research and Review WHO Committee for Proprietary Medicinal Products (CPMP) Clark, 2009, Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine—preliminary report, N Engl J Med, 10.1056/NEJMoa0907650 Greenberg, 2009, response after one dose of a monovalent influenza A (H1N1) 2009 vaccine—preliminary report, N Engl J Med, 10.1056/NEJMoa0907413 Hancock, 2009, Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus, N Engl J Med, 361, 1945, 10.1056/NEJMoa0906453 Falsey, 2009, Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older, J Infect Dis, 200, 172, 10.1086/599790 Ruben, 2004, Inactivated influenza virus vaccines in children, Clin Infect Dis, 38, 678, 10.1086/382883 Frey, 2003, Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults, Vaccine, 21, 4234, 10.1016/S0264-410X(03)00456-0